Advertisement

Topics

KAROLINSKA INVESTMENT FUND Company Profile

19:02 EDT 18th September 2018 | BioPortfolio

KAROLINSKA INVESTMENT FUND
is committed to generating superior capital returns for its investors
engages actively in defining goals and strategies to create attractive companies with globally demanded products invests in pharmaceutical, biotechnology and medical technology companies with a substantial commercial potential contributes with scientific, financial and industrial expertise and networks is managed exclusively by KI Management AB has SEK 600 million under management

Location

Nobels Väg 15a Karolinska Institutet
Stockholm
SE-171 77
Sweden

Contact

Phone: 46 8 - 50 88 44 50
Fax: 46 8 - 50 88 44 59
Email: info@karolinskafund.com


News Articles [898 Associated News Articles listed on BioPortfolio]

Karolinska Development: Investing in innovative business

Jim Van Heusden of Karolinska speaks to Fintan Walton of PharmaVentures about his strategy for the company’s growth, his ambitions for investment opportunities outside Sweden, and the challenges and...

RXi and Karolinska Institutet target solid tumour therapy

US-based biotechnology company RXi Pharmaceuticals has formed a research alliance with the Karolinska Institutet in Stockholm, Sweden, to develop and...Read More... The post RXi and Karolinska Institu...

Karolinska Development AB (publ): Karolinska Development's portfolio company Pharmanest out-licenses Canadian rights for SHACT to Acerus

STOCKHOLM, May 31, 2018. Karolinska Development's portfolio company Pharmanest AB has announced that it has entered into an exclusive agreement with Acerus Pharmaceuticals Corporation pertaining t...

Karolinska tar över medicinsk biobank

Stockholms medicinska biobank övergår i Karolinska universitetssjukhusets regi.

Bono-Backed Investment Fund Props Reflexion Medical In Final Funding Round

RefleXion Medical says it has received Series C funding from The Rise Fund, an investment fund linked to philanthropists such...    

Incanthera clinches £375k cancer treatment funds

Incanthera has been awarded £375,000 from the North West Fund for Biomedical for investment in new cancer treatments. The University of Bradford spin-out company has relocated to Liverpool and w...

Genetic link to IBS identified in women

(Karolinska Institutet) New research coordinated by Karolinska Institutet in Sweden links certain DNA variants to increased risk of irritable bowel syndrome (IBS) in women. The findings, published in ...

Ny vd för Karolinska institutet holding

Hans Möller blir ny vd för koncernen Karolinska institutet holding.

Drugs and Medications [12 Associated Drugs and Medications listed on BioPortfolio]

Act restoring anticavity fluoride cool splash mint [Chattem, Inc.]

ACT Restoring Anticavity Fluoride Mouthwash Cool Splash Mint

Act restoring anticavity fluoride cool splash mint [Chattem, Inc.]

ACT Restoring Anticavity Fluoride Mouthwash Cool Splash Mint 2x

Act restoring anticavity fluoride cool splash spearmint [Chattem, Inc.]

ACT Restoring Anticavity Fluoride Mouthwash Cool Splash Spearmint

Act restoring anticavity fluoride mouthwash cool splash spearmint 2x [Chattem, Inc.]

ACT Restoring Anticavity Fluoride Mouthwash Cool Splash Spearmint 2X

Act restoring anticavity fluoride cool splash vanilla mint [Chattem, Inc.]

ACT Restoring Anticavity Fluoride Mouthwash Cool Splash Vanilla Mint

PubMed Articles [165 Associated PubMed Articles listed on BioPortfolio]

Return on Investment Analysis of Breast Cancer Screening and Downstaging in Egypt: Implications for Developing Countries.

The aim of this study was to perform a return-on-investment (ROI) analysis of a breast cancer screening program in Egypt by comparing net profit in treatment costs saved to program cost investment.

Cecilia Linde MD PhD, Karolinska Institute, Sweden.

The mathematics of market timing.

Market timing is an investment technique that tries to continuously switch investment into assets forecast to have better returns. What is the likelihood of having a successful market timing strategy?...

UK newspaper reporting of the NHS cancer drugs fund, 2010 to 2015: a retrospective media analysis.

Objective We wished to explore how UK national newspapers had covered the creation and operation of the Cancer Drugs Fund from 2010 to 2015. This was introduced to provide cancer patients in England w...

Perioperative haemostasis in children with haemophilia and inhibitors during central venous catheter surgery: The Karolinska model.

Clinical Trials [88 Associated Clinical Trials listed on BioPortfolio]

Effectiveness Study During the First 1,000 Days in Kenya

Malnutrition is a public health problem in Kenya, with 26% of children underfive years of age stunted, and 26% of pre-school children, 26% of women of reproductive age and 42% of pregnant ...

Cluster Randomized, Parallel-group, Prospective, Follow-up Effectiveness Study in Kenyan Children 6-35 Months

Malnutrition is a public health problem in Kenya, with 26% of children under-five years of age stunted, and 26% of pre-school children, 26% of women of reproductive age and 42% of pregnant...

Determine Return on Investment in Heart Failure Remote Monitoring Program

The study will test a hypothesis that the remote monitoring with text and email alerts sent to study subject and optional family/other caregiver (Intervention 1) will have a higher return ...

Asthma and Pest Control Study: Demonstrating Return-on-Investment for In-Home Pest Control for Children With Persistent Asthma

The New York City Department of Health and Mental Hygiene and Montefiore Medical Center, with the Fund for Public Health of New York (FPHNY), DOHMH's fiscal agent, are partnering on a stud...

Stivarga Real Life Evidence in Hungary

The study aims to evaluate use of regorafenib in clinical practice in Hungary. The study should provide information about clinical characteristics of Hungarian regorafenib patients as well...

Companies [1384 Associated Companies listed on BioPortfolio]

KAROLINSKA INVESTMENT FUND

KAROLINSKA INVESTMENT FUND is committed to generating superior capital returns for its investorsengages actively in defining goals and strategies to create attractive companies with globally demanded ...

Accuro Immunology AB

Accuro Immunology is a biomedical discovery company based at Karolinska Institutet in Stockholm, Sweden. Based on its proprietary TEIPP1 technology, Accuro develops active immunotherapies directed at ...

BioPharma Fund

BioPharma Fund is an investment fund that invests in shares of medical biotechnology companies. Biotechnology companies are developing new drugs for many diseases such as cancer, heart disease, diabet...

The Global Health Investment Fund

GHIF is a private investment fund structured by JPMorgan Chase & Co. and the Bill & Melinda Gates Foundation. The fund received anchor support from Grand Challenges Canada (fun...

Aprea AB

Aprea AB is a Swedish biotech company focusing on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53. The Company's lead pro...

More Information about "KAROLINSKA INVESTMENT FUND" on BioPortfolio

We have published hundreds of KAROLINSKA INVESTMENT FUND news stories on BioPortfolio along with dozens of KAROLINSKA INVESTMENT FUND Clinical Trials and PubMed Articles about KAROLINSKA INVESTMENT FUND for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of KAROLINSKA INVESTMENT FUND Companies in our database. You can also find out about relevant KAROLINSKA INVESTMENT FUND Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record